Home/Intract Pharma/Dr. Maurits Kleijnen
DM

Dr. Maurits Kleijnen

Head of Research

Intract Pharma

Intract Pharma Pipeline

DrugIndicationPhase
Oral Anti-TNFα AntibodyInflammatory/Autoimmune Diseases (e.g., Rheumatoid Arthritis, IBD)Preclinical